טוען...
Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
Anti-infective treatment of pulmonary exacerbations is a major issue in people with cystic fibrosis (CF). Individualized dosing strategies and adaptation of infusion times are important concepts to optimize anti-infective therapy. In this prospective non-randomized controlled open-label trial, we co...
שמור ב:
| הוצא לאור ב: | Antibiotics (Basel) |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7998425/ https://ncbi.nlm.nih.gov/pubmed/33799542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10030292 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|